OS Therapies Incorporated OSTX
0.89 USD -0.03 (-3.27%)
At closeNov 10, 2026, 6:07 PM EST
0.91 +0.02 +2.60%
After hours · Nov 10, 6:07 PM ET
0.8601 Day range 0.98005
0.89 52-week range 2.24
- YTD
- -36.43%
- 1 year
- -54.12%
- Market cap
- 41.66M
- EPS (ttm)
- -1.08
- Shares out
- 21.24M
- Forward P/E
- 2.57
- YTD return
- -36.43%
- 1-year return
- -54.12%
- Volume
- 402.19K
- Avg volume
- 674.57K
- Open
- 0.9576
- Previous close
- 0.9201
- Day's range
- 0.8601 – 0.98005
- 52-week range
- 0.89 – 2.24
- Price target
- 12.67 (+1323.2%)
5D -0.3000 (-25.21%)
Key statistics
- Enterprise value
- 62.55M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 94.92K
- Total debt
- 16.70M
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 2.72
- 200-day average
- 3.11
Analyst view
Price target (mean) 12.67 +1323.2% upside
Now 0.89
- Target (low)
- 8.00
- Target (mean)
- 12.67
- Target (high)
- 21.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.14.
Financials — quick view
OSTX Revenue — quarterly 0
OSTX Net income — quarterly -8.63M
OSTX EPS — quarterly -0.20
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 26, 2024 | Maxim Group | init | — | Buy |
| Oct 3, 2024 | EF Hutton | main | Buy | Buy |
| Sep 16, 2024 | EF Hutton | main | Buy | Buy |
| Sep 3, 2024 | EF Hutton | init | — | Buy |
About OS Therapies Incorporated
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- ostherapies.com
News
OS Therapies Initiates CMAA Process With UK MHRA For Herlystic In Prevention Or Delay Of Recurrence In Fully Resected, Pulmonary Metastatic Osteosarcoma; Expects To Complete CMAA Process Later In Q4 Of 2026 
OS Therapies Initiates U.K. MHRA Conditional Marketing Authorisation Application for Herlystic (OST-HER2) in the Prevention or Delay of Recurrence in Fully Resected, Pulmonary Metastatic Osteosarcoma 
OS Therapies Completes Requalification of Phase 2b Herlystic (OST-HER2) Drug Substance for Confirmatory Phase 3 Trial 
OS Therapies Announces Initial Closing of Warrant Exercise Inducement and Exchange Offer for Initial Gross Proceeds of Approximately $7.2 Million 
Rubenstein Public Relations Named Agency of Record for OS Therapies 
OS Therapies' OSAH Subsidiary Receives U.S. Department Of Agriculture Guidance On Commercial Deployment Pathway For OST-HER2 To Treat Canine Osteosarcoma 
OS Animal Health Receives USDA Feedback on Regulatory Pathway for OST-HER2 in Canine Osteosarcoma 
OS Therapies Reports Significant Three-Year Survival Data for Bone Cancer Treatment 
OS Therapies Reports Significant Three-Year Survival Data for Bone Cancer Treatment 
OS Therapies Announces Statistically Significant Final 3-Yr Overall Survival Benefit For OST-HER2-Treated Patients In Phase 2b Trial In Pulmonary Metastatic Osteosarcoma Compared With Combined Published Historical Control
Your note
Sign in to keep a note on OSTX — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Millennium Management Llc | 0.28% | 60,435 | 228.44K | Sep 29, 2024 |
| CM Management, LLC | 0.24% | 50,000 | 189.00K | Sep 29, 2024 |
| Delta Investment Management, LLC | 0.09% | 18,081 | 68.35K | Sep 29, 2024 |
| HRT Financial LP | 0.08% | 17,576 | 66.44K | Sep 29, 2024 |
| Virtu Financial LLC | 0.05% | 10,045 | 37.97K | Sep 29, 2024 |
| UBS Group AG | 0.02% | 3,806 | 14.39K | Sep 29, 2024 |